Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PRVA | SOUN |
|---|---|---|
| Price | $20.45 | $5.88 |
| Change today | ▲ 0.74% | ▲ 0.68% |
| Market cap | $2.61B | $2.61B |
| Return, 3 months | -24.9% | -11.4% |
| Return, year to date | -13.7% | -41.0% |
| Return, 1 year | -15.3% | -67.8% |
| P/E (TTM) | 93.0 | -9.5 |
| P/B | 3.3 | 5.3 |
| P/E percentile vs own 5y | – | 54th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +56.5% | +87.1% |
| Analyst buy share | 90% | 75% |
| RSI (14) | 51 | 39 |
| 30-day volatility | 19.1% | 38.1% |
| Max drawdown, 1 year | -32.0% | -73.4% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
